These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
76 related items for PubMed ID: 16949155
1. Genetic variations in benzene metabolism and susceptibility to multiple myeloma. Lincz LF, Scorgie FE, Robertson R, Enno A. Leuk Res; 2007 Jun; 31(6):759-63. PubMed ID: 16949155 [Abstract] [Full Text] [Related]
2. Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma. Casson AG, Zheng Z, Porter GA, Guernsey DL. Cancer Detect Prev; 2006 Jun; 30(5):423-31. PubMed ID: 17064856 [Abstract] [Full Text] [Related]
3. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer. van der Logt EM, Bergevoet SM, Roelofs HM, Te Morsche RH, Dijk Yv, Wobbes T, Nagengast FM, Peters WH. Mutat Res; 2006 Jan 29; 593(1-2):39-49. PubMed ID: 16039674 [Abstract] [Full Text] [Related]
4. Xenobiotic gene polymorphisms and susceptibility to multiple myeloma. Lincz LF, Kerridge I, Scorgie FE, Bailey M, Enno A, Spencer A. Haematologica; 2004 May 29; 89(5):628-9. PubMed ID: 15136237 [Abstract] [Full Text] [Related]
5. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Gresner P, Gromadzinska J, Wasowicz W. Lung Cancer; 2007 Jul 29; 57(1):1-25. PubMed ID: 17337085 [Abstract] [Full Text] [Related]
6. GSTM1 and codon 72 P53 polymorphism in multiple myeloma. Ortega MM, Honma HN, Zambon L, Lorand-Metze I, Costa FF, De Souza CA, Lima CS. Ann Hematol; 2007 Nov 29; 86(11):815-9. PubMed ID: 17653713 [Abstract] [Full Text] [Related]
7. A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk. Spurdle AB, Chang JH, Byrnes GB, Chen X, Dite GS, McCredie MR, Giles GG, Southey MC, Chenevix-Trench G, Hopper JL. Cancer Epidemiol Biomarkers Prev; 2007 Apr 29; 16(4):769-74. PubMed ID: 17416769 [Abstract] [Full Text] [Related]
8. [Relationship of genetic polymorphism of microsomal epoxide hydrolase with susceptibility of chronic benzene poisoning]. Zhang ZB, Gu SY, Wan JX, Jin XP, Xia ZL. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Jun 29; 22(3):176-80. PubMed ID: 15256148 [Abstract] [Full Text] [Related]
9. The Tyr113His polymorphism in exon 3 of the microsomal epoxide hydrolase gene is a risk factor for perinatal mortality. Raijmakers MT, de Galan-Roosen TE, Schilders GW, Merkus JM, Steegers EA, Peters WH. Acta Obstet Gynecol Scand; 2004 Nov 29; 83(11):1056-60. PubMed ID: 15488121 [Abstract] [Full Text] [Related]
10. Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia. Bajpai P, Tripathi AK, Agrawal D. Leuk Res; 2007 Oct 29; 31(10):1359-63. PubMed ID: 17420047 [Abstract] [Full Text] [Related]
11. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Singh M, Shah PP, Singh AP, Ruwali M, Mathur N, Pant MC, Parmar D. Mutat Res; 2008 Feb 01; 638(1-2):184-94. PubMed ID: 18035380 [Abstract] [Full Text] [Related]
12. Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility. Lacko M, Oude Ophuis MB, Peters WH, Manni JJ. Anticancer Res; 2009 Feb 01; 29(2):753-61. PubMed ID: 19331232 [Abstract] [Full Text] [Related]
13. Susceptibility to pre-eclampsia is associated with multiple genetic polymorphisms in maternal biotransformation enzymes. Zusterzeel PL, Peters WH, Burton GJ, Visser W, Roelofs HM, Steegers EA. Gynecol Obstet Invest; 2007 Feb 01; 63(4):209-13. PubMed ID: 17167268 [Abstract] [Full Text] [Related]
14. Microsomal epoxide hydrolase genotypes and the risk for head and neck cancer. Lacko M, Roelofs HM, Te Morsche RH, Voogd AC, Oude Ophuis MB, Peters WH, Manni JJ. Head Neck; 2008 Jul 01; 30(7):836-44. PubMed ID: 18383527 [Abstract] [Full Text] [Related]
15. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer. Nordgard SH, Ritchie MD, Jensrud SD, Motsinger AA, Alnaes GI, Lemmon G, Berg M, Geisler S, Moore JH, Lønning PE, Børresen-Dale AL, Kristensen VN. Pharmacogenet Genomics; 2007 Feb 01; 17(2):127-36. PubMed ID: 17301692 [Abstract] [Full Text] [Related]
16. [Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility]. González A, Ramírez V, Cuenca P, Sierra R. Rev Biol Trop; 2004 Sep 01; 52(3):591-600. PubMed ID: 17361553 [Abstract] [Full Text] [Related]
17. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB. Carcinogenesis; 2007 Jul 01; 28(7):1455-62. PubMed ID: 17307803 [Abstract] [Full Text] [Related]
18. Protective role of CYP1A1*2A in the development of multiple myeloma. Kang SH, Kim TY, Kim HY, Yoon JH, Cho HI, Yoon SS, Kang DH, Suh CW, Lee JH, Lee DS. Acta Haematol; 2008 Jul 01; 119(1):60-4. PubMed ID: 18285692 [Abstract] [Full Text] [Related]
19. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study. Manfredi S, Federici C, Picano E, Botto N, Rizza A, Andreassi MG. Mutat Res; 2007 Aug 01; 621(1-2):106-12. PubMed ID: 17408703 [Abstract] [Full Text] [Related]
20. Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma. Mössner R, Anders N, König IR, Krüger U, Schmidt D, Berking C, Ziegler A, Brockmöller J, Kaiser R, Volkenandt M, Westphal GA, Reich K. Arch Dermatol Res; 2007 Jan 01; 298(8):371-9. PubMed ID: 17072629 [Abstract] [Full Text] [Related] Page: [Next] [New Search]